Murawska M - Search Results

1

Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients.

Felisiak-Golabek A, Rembiszewska A, Rzepecka IK, Szafron L, Madry R, Murawska M, Napiorkowski T, Sobiczewski P, Osuch B, Kupryjanczyk J; Polish Ovarian Cancer Study Group (POCSG). Felisiak-Golabek A, et al. Among authors: murawska m. J Ovarian Res. 2011 Nov 10;4(1):20. doi: 10.1186/1757-2215-4-20. J Ovarian Res. 2011. PMID: 22075440 Free PMC article.

2

PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients.

Kolasa IK, Rembiszewska A, Felisiak A, Ziolkowska-Seta I, Murawska M, Moes J, Timorek A, Dansonka-Mieszkowska A, Kupryjanczyk J. Kolasa IK, et al. Among authors: murawska m. Cancer Biol Ther. 2009 Jan;8(1):21-6. doi: 10.4161/cbt.8.1.7209. Epub 2009 Jan 17. Cancer Biol Ther. 2009. PMID: 19029838 Free article.

3

Androgen, progesterone, and FSH receptor polymorphisms in ovarian cancer risk and outcome.

Ludwig AH, Murawska M, Panek G, Timorek A, Kupryjanczyk J. Ludwig AH, et al. Among authors: murawska m. Endocr Relat Cancer. 2009 Sep;16(3):1005-16. doi: 10.1677/ERC-08-0135. Epub 2009 May 20. Endocr Relat Cancer. 2009. PMID: 19458022

4

The effect of early detection of occult brain metastases in HER2-positive breast cancer patients on survival and cause of death.

Niwińska A, Tacikowska M, Murawska M. Niwińska A, et al. Among authors: murawska m. Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1134-9. doi: 10.1016/j.ijrobp.2009.06.030. Epub 2009 Nov 24. Int J Radiat Oncol Biol Phys. 2010. PMID: 19932944

5

New breast cancer recursive partitioning analysis prognostic index in patients with newly diagnosed brain metastases.

Niwińska A, Murawska M. Niwińska A, et al. Among authors: murawska m. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):2065-71. doi: 10.1016/j.ijrobp.2010.10.077. Epub 2011 May 17. Int J Radiat Oncol Biol Phys. 2012. PMID: 21596487

6

Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients.

Pogoda K, Niwińska A, Murawska M, Pieńkowski T. Pogoda K, et al. Among authors: murawska m. Med Oncol. 2013 Mar;30(1):388. doi: 10.1007/s12032-012-0388-4. Epub 2013 Jan 5. Med Oncol. 2013. PMID: 23292831 Free PMC article.

7

Breast cancer subtypes and response to systemic treatment after whole-brain radiotherapy in patients with brain metastases.

Niwińska A, Murawska M, Pogoda K. Niwińska A, et al. Among authors: murawska m. Cancer. 2010 Sep 15;116(18):4238-47. doi: 10.1002/cncr.25391. Cancer. 2010. PMID: 20549816 Free article.

8

Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT).

Niwińska A, Murawska M, Pogoda K. Niwińska A, et al. Among authors: murawska m. Ann Oncol. 2010 May;21(5):942-8. doi: 10.1093/annonc/mdp407. Epub 2009 Oct 19. Ann Oncol. 2010. PMID: 19840953 Free article.

9

Breast cancer leptomeningeal metastasis--the role of multimodality treatment.

Rudnicka H, Niwińska A, Murawska M. Rudnicka H, et al. Among authors: murawska m. J Neurooncol. 2007 Aug;84(1):57-62. doi: 10.1007/s11060-007-9340-4. Epub 2007 Feb 20. J Neurooncol. 2007. PMID: 17310266 Clinical Trial.

10

Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes.

Niwińska A, Olszewski W, Murawska M, Pogoda K. Niwińska A, et al. Among authors: murawska m. J Neurooncol. 2011 Dec;105(3):547-53. doi: 10.1007/s11060-011-0616-3. Epub 2011 Jun 9. J Neurooncol. 2011. PMID: 21656328 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters